The recent paper by Daley-Yates et al.
Fuglsang
Anders
A
Thyroff-Friesinger
Ursula
U
Gross
Jens
J
D000280:Administration, Inhalation; D000420:Albuterol / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D000730:Androstadienes / Q000008:administration & dosage / Q000493:pharmacokinetics*; D019540:Area Under Curve; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D004338:Drug Combinations; D005062:European Union; D000068297:Fluticasone-Salmeterol Drug Combination; D017408:Guidelines as Topic; D006801:Humans; D009330:Nebulizers and Vaporizers; D013810:Therapeutic Equivalency
D000730:Androstadienes; D001993:Bronchodilator Agents; D004338:Drug Combinations; D000068297:Fluticasone-Salmeterol Drug Combination; D000420:Albuterol